NewEdge Advisors LLC Acquires 11,740 Shares of Cardinal Health, Inc. $CAH

Posted by Brian Himes on Aug 11th, 2026

NewEdge Advisors LLC lifted its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 52.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,939 shares of the company’s stock after purchasing an additional 11,740 shares during the quarter. NewEdge Advisors LLC’s holdings in Cardinal Health were worth $7,172,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of CAH. Kathmere Capital Management LLC grew its position in Cardinal Health by 1.2% during the first quarter. Kathmere Capital Management LLC now owns 4,242 shares of the company’s stock valued at $896,000 after acquiring an additional 49 shares during the last quarter. Hillsdale Investment Management Inc. grew its holdings in shares of Cardinal Health by 0.9% during the 4th quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock valued at $1,184,000 after purchasing an additional 50 shares during the last quarter. V Square Quantitative Management LLC raised its position in Cardinal Health by 2.6% in the 1st quarter. V Square Quantitative Management LLC now owns 2,002 shares of the company’s stock worth $423,000 after purchasing an additional 50 shares during the period. Generali Asset Management SPA SGR boosted its position in Cardinal Health by 11.0% during the fourth quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock valued at $105,000 after buying an additional 51 shares during the period. Finally, Stephens Inc. AR grew its stake in shares of Cardinal Health by 0.9% during the fourth quarter. Stephens Inc. AR now owns 5,951 shares of the company’s stock valued at $1,223,000 after buying an additional 52 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 0.2%

Shares of Cardinal Health stock opened at $236.77 on Tuesday. The company has a market capitalization of $55.45 billion, a price-to-earnings ratio of 36.20, a PEG ratio of 1.16 and a beta of 0.49. The stock’s 50-day simple moving average is $227.47 and its 200-day simple moving average is $216.44. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $244.87.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CAH. TD Cowen boosted their target price on shares of Cardinal Health from $255.00 to $275.00 and gave the company a “buy” rating in a report on Thursday, July 9th. Mizuho lifted their price target on shares of Cardinal Health from $235.00 to $240.00 and gave the company an “outperform” rating in a research report on Thursday, July 23rd. Morgan Stanley boosted their price objective on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 28th. Wells Fargo & Company cut their price objective on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Finally, William Blair initiated coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They set an “outperform” rating for the company. Fifteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and an average target price of $251.73.

Check Out Our Latest Analysis on CAH

Cardinal Health Company Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.